Susceptibility to thyroid disorders in hepatitis C

Clinical Gastroenterology and Hepatology

Volumn 3, Issue 6, 2005, Pages 595-603

  Muratori, Luigi ^a,c   Bogdanos, Dimitrios P ^b   Muratori, Paolo ^a   Lenzi, Marco ^a   Granito, Alessandro ^a   Ma, Yun ^b   Mieli Vergani, Giorgina ^b   Bianchi, Francesco B ^a   Vergani, Diego ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AUTOANTIBODY; AUTOANTIGEN; CYTOCHROME P450 2D6; EPITOPE; INTERFERON; MICROSOME ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY; VIRUS PROTEIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CROSS REACTION; DISEASE PREDISPOSITION; FEMALE; HEPATITIS C; HUMAN; KIDNEY; KIDNEY MICROSOME; LIVER; LIVER DISEASE; LIVER MICROSOME; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; THYROID DISEASE; THYROID FUNCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; AUTOANTIBODIES; DISEASE SUSCEPTIBILITY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; INTERFERON-ALPHA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA, VIRAL; THYROID DISEASES; THYROID HORMONES;

EID: 20444487228     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(05)00018-2     Document Type: Article

References (48)

1. N. Abuaf, F. Lunel, P. Giral Non-organ specific autoantibodies associated with chronic C virus hepatitis J Hepatol 18 1993 359 364
2. F. Bortolotti, P. Vajro, F. Balli Non-organ specific autoantibodies in children with chronic hepatitis C J Hepatol 25 1996 614 620
3. B.D. Clifford, D. Donahue, L. Smith High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C Hepatology 21 1995 613 619
4. M. Lenzi, S. Bellentani, G. Saccoccio Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population a nested case-control study of the Dionysos cohort Gut 45 1999 435 441
5. P. Muratori, L. Muratori, T. Stroffolini Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population Clin Exp Immunol 131 2003 118 121
6. D. Pateron, D.J. Hartmann, J.C. Duclos-Vallee Latent autoimmune thyroid disease in patients with chronic HCV hepatitis J Hepatol 17 1993 417 419
7. A. Tran, J.F. Quaranta, S. Benzaken High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy Hepatology 18 1993 253 257
8. J. Matsuda, N. Saitoh, M. Gotoh High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha Am J Gastroenterol 90 1995 1138 1141
9. C. Ploix, S. Verber, P. Chevallier-Queyron Hepatitis C virus infection is frequently associated with high titers of anti-thyroid antibodies Int J Immunopathol Pharmacol 12 1999 121 126
10. E. Gorez, I. Nakib, H. Larbre Lack of epidemiological evidence for a link between thyroid auto-immune disease and hepatitis C virus infection J Hepatol 26 1997 738 739
11. Y.H. Chung, Y.K. Shong Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis Am J Gastroenterol 88 1993 244 247
12. P. Marcellin, M. Pouteau, J.P. Benhamou Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction J Hepatol 22 1995 364 369
13. M.C. Hsieh, M.L. Yu, W.L. Chuang Virologic factors related to interferon-alpha-induced thyroid dysfunction in patients with chronic hepatitis C Eur J Endocrinol 142 2000 431 437
14. G. Mazziotti, F. Sorvillo, G. Stornaiuolo Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis a prospective study J Endocrinol Invest 25 2002 624 630
15. D.P. Bogdanos, M. Lenzi, Y. Ma Cross-reactive immunity explains thyroid autoimmunity in Liver/Kidney Microsomal-1 positive hepatitis C virus infected patients Hepatology 30 1999 460A
16. F. Alvarez, P. Berg, F. Bianchi International Autoimmune Hepatitis Group Report review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938
17. L. Muratori, M. Cataleta, P. Muratori Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting comparison of different techniques J Immunol Methods 187 1995 259 264
18. L. Muratori, M. Lenzi, Y. Ma Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease Gut 37 1995 406 412
19. D.P. Bogdanos, H. Baum, U.C. Sharma Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis J Hepatol 36 2002 14 21
20. D.P. Bogdanos, H. Baum, A. Grasso Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis J Hepatol 40 2004 43 51
21. W. van 't Hof, F.J. van Milligen, P.C. Driedijk How to demonstrate specificity of antibody binding to synthetic peptides? J Immunol Methods 161 1993 273 275
22. D. Bogdanos, M. Lenzi, M. Okamoto Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA b51 Int J Immunopathol Pharmacol 17 2004 83 92
23. G.V. Gregorio, K. Choudhuri, Y. Ma Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection J Immunol 162 1999 1802 1810
24. N. Kerkar, K. Choudhuri, Y. Ma Cytochrome P4502D6(193-212) a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease J Immunol 170 2003 1481 1489
25. S.J. Rodda, G. Tribbick Antibody-defined epitope mapping using the multipin method of peptide synthesis Methods 9 1996 473 481
26. K. Choudhuri, G.V. Gregorio, G. Mieli-Vergani Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis Hepatology 28 1998 1177 1181
27. L. Muratori, M. Lenzi, M. Cataleta Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C J Hepatol 21 1994 199 203
28. C. Sategna-Guidetti, U. Volta, C. Ciacci Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal an Italian multicenter study Am J Gastroenterol 96 2001 751 757
29. F. Cassani, M. Cataleta, P. Valentini Serum autoantibodies in chronic hepatitis C comparison with autoimmune hepatitis and impact on the disease profile Hepatology 26 1997 561 566
30. F. Bortolotti, L. Muratori, P. Jara Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children J Pediatr 142 2003 185 190
31. K.R. Reddy, E.L. Krawitt, J.C. Homberg Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of America J Viral Hepat 2 1995 175 179
32. D. Vergani, F. Alvarez, F.B. Bianchi Liver autoimmune serology a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group J Hepatol 41 2004 677 683
33. L. Todros, G. Saracco, M. Durazzo Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes Hepatology 22 1995 1374 1378
34. L. Garcia-Buey, C. Garcia-Monzon, S. Rodriguez Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C Gastroenterology 108 1995 1770 1777
35. J.C. Duclos-Vallee, M. Nishioka, N. Hosomi Interferon therapy in LKM-1 positive patients with chronic hepatitis C follow-up by a quantitative radioligand assay for CYP2D6 antibody detection J Hepatol 28 1998 965 970
36. Y. Iijima, T. Kato, H. Miyakawa Effect of interferon therapy on Japanese chronic hepatitis C virus patients with anti-liver/kidney microsome autoantibody type 1 J Gastroenterol Hepatol 16 2001 782 788
37. M.B. Oldstone Molecular mimicry and immune-mediated diseases Faseb J 12 1998 1255 1265
38. J.L. Croxford, J.K. Olson, S.D. Miller Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis Autoimmun Rev 1 2002 251 260
39. Z.S. Zhao, F. Granucci, L. Yeh Molecular mimicry by herpes simplex virus-type 1 autoimmune disease after viral infection Science 279 1998 1344 1347
40. V. Panoutsakopoulou, M.E. Sanchirico, K.M. Huster Analysis of the relationship between viral infection and autoimmune disease Immunity 15 2001 137 147
41. J.A. James, J.B. Harley B-cell epitope spreading in autoimmunity Immunol Rev 164 1998 185 200
42. C.L. Vanderlugt, S.D. Miller Epitope spreading in immune-mediated diseases implications for immunotherapy Nat Rev Immunol 2 2002 85 95
43. P.L. Arscott, R.J. Koenig, M.M. Kaplan Unique autoantibody epitopes in an immunodominant region of thyroid peroxidase J Biol Chem 271 1996 4966 4973
44. M. Beld, M. Penning, M. van Putten Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users impact of epitope variation and relationship to detection of HCV RNA in blood Hepatology 29 1999 1288 1298
45. V. Estienne, C. Duthoit, L. Vinet A conformational B-cell epitope on the C-terminal end of the extracellular part of human thyroid peroxidase J Biol Chem 273 1998 8056 8062
46. M. Rodriguez-Lopez, J.I. Riezu-Boj, M. Ruiz Immunogenicity of variable regions of hepatitis C virus proteins selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA J Gen Virol 80 Pt 3 1999 727 738
47. Y. Ma, M.G. Thomas, M. Okamoto Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule J Immunol 169 2002 277 285
48. L. Muratori, D. Zauli, F. Giostra LKM1 appearance in a HLA-DR3+ patient with chronic hepatitis C during interferon treatment J Hepatol 18 1993 259 260